| FNGR 0.398 129.53% | CHAI 0.4 57.11% | LGCL 0.0389 -27.02% | CYAB 0.4467 45.36% | NVDA 217.55 -4.57% | CHGA 2.852 2,082.10% | PCG 16.6 -7.52% | NCPL 0.6916 28.41% | NVD 4.05 8.58% | BITO 10.45 -3.06% | IREN 35.45 -12.53% | INTC 89.47 -2.85% | NU 14.3 -3.90% | IBIT 43.9 -3.07% | XTNT 0.384 16.36% | TSLL 8.98 -3.54% | ONDS 7.9 -9.71% | DUO 0.9602 37.56% | AAL 13.64 -0.58% | SOAR 0.2169 5.80% | SOXL 111.34 -9.52% | BTAI 0.1814 -74.76% | TQQQ 71.85 -1.98% | ETHA 18.37 -2.65% | FTFT 2.2188 281.50% | SPCX 141.5 0.45% | PATH 18.15 -0.98% | BMNR 23.8 -7.14% | NOK 10.21 -3.59% | AMZN 266.43 3.97% | MRVL 216.62 -10.28% | SOXS 49.82 9.86% | WHLR 1.07 -4.46% | SQQQ 38.54 2.03% | PLUG 2.19 -3.52% | SOFI 18.06 -5.84% | AEMD 2.49 14.75% | SPDN 8.49 0.12% | QID 14.24 1.42% | MARA 10.67 -10.11% | KEEL 3.23 -7.98% | GDX 99.65 -3.90% | RIVN 16.07 -4.35% | F 13.87 -0.57% | BTG 5.66 -2.92% | AAPL 319.7 1.63% | PURR 11.61 -9.51% | SMR 9.29 -4.62% | VALE 15.03 -1.83% | SPY 769.35 -0.23%

Axon Enterprise, Inc. (NASDAQ:AXON) Coverage Initiated by RBC Capital

Axon Enterprise, Inc. (NASDAQ:AXON) is a leading provider of public safety technology, known for its TASER devices and body-worn cameras. The company is expanding its product portfolio to include virtual reality training and counter-drone equipment. Axon competes with other tech firms in the public safety sector, focusing on innovative solutions to enhance law enforcement and public safety operations.

On November 17, 2025, RBC Capital initiated coverage on AXON with a bullish view, assigning it an "Outperform" grade. At the time, the stock price was $554.37. This positive outlook aligns with the company's strong performance in its Connected Devices segment, where revenues rose by 24% year over year to $405 million in Q3 2025, driven by demand for TASER 10 and Body 4 products.

The TASER and Personal Sensors businesses saw growth of 17% and 20%, respectively, while the Platform Solutions segment experienced a remarkable 71% increase. This growth is supported by the global demand for public safety technology, which continues to expand Axon's product offerings. The introduction of the next-generation TASER 10 and Axon Body 4 has significantly contributed to this success.

Wall Street analysts are optimistic about Axon's future, as reflected in the company's average brokerage recommendation (ABR) of 1.45, indicating a position between Strong Buy and Buy. Out of 19 brokerage firms, 13 have given Axon a Strong Buy rating, while three have rated it as a Buy. This positive sentiment can influence the stock's price, making it an attractive option for investors.

Currently, AXON's stock price is $554.37, reflecting a slight decrease of 0.52% or $2.92. The stock has traded between $546.64 and $569.04 today. Over the past year, AXON reached a high of $885.92 and a low of $469.24. The company's market capitalization is approximately $43.75 billion, with a trading volume of 823,617 shares on the NASDAQ.

Published on: November 17, 2025